Amgen Czech Republic
Presence
Amgen is one of the...
- Forbes Global 2000 (#193);
- Fortune 500 (#151);
- Nasdaq 100;
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
Amgen is a company listed under the stock ticker AMGN (US).
Amgen has a direct presence in 21 countries.Amgen has 24 subsidiaries including Amgen APAC, Amgen Argentina and Amgen Australia.
They are in:
- Pharmaceuticals84%
- Biotechnology16%
Acquisition, funding and merger involving Amgen.
- Amgen Rare Disease and Amgen have announced they will merge (posted on October 10 2023)..
- Amgen has announced the acquisition of Amgen Rare Disease (posted on December 12 2022).
- Amgen has acquired ChemoCentryx (posted on October 21 2022).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Amgen Czech Republic
- Tomas Brezina, Managing Director
- Przemysław Bukowy, Law Legal Counsel
- Filip Harvánek, Business Unit Senior Manager, Oncology
Create your alert
to follow the executive moves at Amgen Czech Republic.
Pharmaceuticals
Amgen has 1,837 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- Molex has announced the acquisition of Vectura Group (posted on September 23 2024).
- Agilent Technologies has acquired BioVectra (posted on September 23 2024).
- OXB will change its company name to OXB on Sep 18, 2024. (posted on September 18 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Amgen Czech Republic
Social media about Amgen Czech Republic
- Amgen Czech Republic on Wikipedia, Google News & Yahoo Finance
- Amgen Czech Republic on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Tomas Brezina 
Call Amgen Czech Republic at +420 22...
